Home > Insider Trading > Filing (0001121781-15-000197)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
924515	Guided Therapeutics Inc	GTHP	Electromedical & Electrotherapeutic Apparatus (3845)	582029543

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1348439	E John Imhoff	3215 Shrine Road Suite 6 Brunswick GA 31520		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-29	18,752	$0.00	9,904,725	No	4	P	Direct
Common Stock	Acquisiton	2015-06-30	113,636	$0.00	9,885,973	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options	Acquisiton	2015-05-29	600,000	$0.00	600,000	$0.10
Common Stock	Tranche A Warrants	Disposition	2015-06-19	367,647	$0.00	367,647	$1.08
Common Stock	Tranche B Warrants	Disposition	2015-06-19	3,797,789	$0.00	3,797,789	$0.10
Common Stock	Tranche A Warrants	Acquisiton	2015-06-19	367,647	$0.00	367,647	$0.10
Common Stock	Tranche B Warrants	Acquisiton	2015-06-19	3,797,789	$0.00	3,797,789	$0.09
Common Stock	Warrants	Disposition	2015-06-30	58,935	$0.00	58,935	$0.23
Common Stock	Warrants	Acquisiton	2015-06-30	58,935	$0.00	58,935	$0.11
Common Stock	Warrants	Acquisiton	2015-06-30	58,935	$0.00	58,938	$0.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
600,000	2015-05-29	2025-05-28	No	4	A	Direct
0	2013-05-22	2018-05-22	No	4	S	Direct
0	2013-05-22	2018-05-22	No	4	S	Direct
367,647	2013-05-22	2018-05-22	No	4	P	Direct
3,797,789	2013-05-22	2018-05-22	No	4	P	Direct
0	2014-12-02	2019-12-02	No	4	S	Direct
58,935	2015-12-02	2020-12-02	No	4	P	Direct
58,935	2015-12-02	2020-12-02	No	4	P	Direct

Footnotes

On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
These shares were granted as dividend on the issuer's Series B preferred stock.
These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.
On June 19, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock in an exchange with the issuer.